Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel

The performance of immune checkpoint inhibitors, which benefit only a subset of patients and can cause serious immune-related adverse events, underscores the need for strategies that induce T-cell immunity with minimal toxicity. The gut microbiota has been implicated in the outcomes of patients foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Kai, Nam, Jutaek, Xu, Jin, Sun, Xiaoqi, Huang, Xuehui, Animasahun, Olamide, Achreja, Abhinav, Jeon, Jin Heon, Pursley, Benjamin, Kamada, Nobuhiko, Chen, Grace Y., Nagrath, Deepak, Moon, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595497/
https://www.ncbi.nlm.nih.gov/pubmed/34168321
http://dx.doi.org/10.1038/s41551-021-00749-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595497/
https://www.ncbi.nlm.nih.gov/pubmed/34168321
http://dx.doi.org/10.1038/s41551-021-00749-2

Ejemplares similares